NCT05858307|Recruiting
Loading search results
Sponsor study identifier
observational
300
1 country
1
Study Start
June 22, 2022
Actual (reported)Primary Completion
June 30, 2026
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Study Completion
December 31, 2026
EstimatedPlanned date reported by the registry; this milestone is not confirmed as achieved.
This study aims to assess the association of Anti-Müllerian hormone (AMH) with polycystic ovarian syndrome, premature ovarian insufficiency and fertility. The main objectives include the following:
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
December 31, 2026
EstimatedPlanned date reported by the registry; this milestone is not confirmed as achieved.
Click on a node to explore related trials.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
June 22, 2022
Actual (reported)February 6, 2023
Actual (reported)May 15, 2023
Actual (reported)June 30, 2026
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
December 31, 2026
EstimatedPlanned date reported by the registry; this milestone is not confirmed as achieved.
Serum anti-Müllerian hormone (AMH) (pmol/L)
To evaluate the serum AMH level of women who undergo investigation for polycystic ovarian syndrome (PCOS), premature ovarian insufficiency (POI) or subfertility
Within 1 to 2 months after the day of recruitment
Type of gonadotropin used for ovarian stimulation
From the first 1 day to last 1 day of ovarian stimulation during ART treatment
Total gonadotropin dose used for ovarian stimulation
On the last 1 day of ovarian stimulation during ART treatment
The following clients will be included in our study population. * Women attending the Paediatric and Adolescent Gynaecological Clinic and Gynaecological Endocrine Clinic of in the Department of Obstetrics and Gynaecology at the Prince of Wales Hospital for the management of PCOS and POI * Women attending the Assisted Reproductive Technology (ART) Unit of The Chinese University of Hong Kong for ART treatment
The Chinese University of Hong Kong
Hong Kong, Hong Kong
Serum
PUI WAH JACQUELINE CHUNG
Chinese University of Hong Kong
First Submitted
February 6, 2023
First Posted
May 15, 2023
Study Start
June 22, 2022
Actual (reported)Primary Completion
June 30, 2026
Estimated (date passed)Follicular FSH Serum Level as a Predictor of an Oocyte Yield and Quality in Fertility Preservation Cycles for Women With a Compromised Ovarian Reserve
Number of oocytes retrieved
On the 1 day of oocyte retrieval during ART treatment
Serum follicle stimulation hormone (FSH) (IU/L)
On the first 1 day of ovarian stimulation during ART treatment
Serum luteinising hormone (LH) (IU/L)
On the first 1 day of ovarian stimulation during ART treatment
Contact the study team to confirm eligibility.
This estimate has passed. The registry has not confirmed an actual date for this milestone.
Study Completion
December 31, 2026
EstimatedPlanned date reported by the registry; this milestone is not confirmed as achieved.
Last Updated
March 27, 2025
Record last verified: 2025-03
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: